Messenger RNA–based therapeutics and vaccines are the new hope in the fight against incurable diseases. A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on the ...
Tenecteplase is a third-generation thrombolytic agent that has a favourable pharmacological profile, compared with alteplase. Tenecteplase has a longer half-life, which allows administration in a ...